AveXis receives FDA approval for Zolgensma, the first and only gene therapy for pediatric patients with spinal muscular atrophy (SMA) Read more
GSK announces approval of Shingrix in China for prevention of shingles in adults aged 50 and over Read more
ProBioGen and Abcuro signed GlymaxX-Improved Cell Line Development and GMP Production Agreement Read more
Santhera Enters into License Agreement with Chiesi Group for Raxone in LHON Valued at up to CHF 105 Million Read more
CALECIM(R) forms a major partnership with Menarini Asia-Pacific to expand the presence of its stem cell skin care products in the region Read more
Aequus to supply Kensington Eye Institute with Zepto Capsulotomy system; Extends Distribution Agreement with Mynosys Read more
Halozyme Announces argenx Has Selected Second Target Under ENHANZE Technology Collaboration And License Agreement Read more